Antonio Linares
@alc2022
100x investor, bio/acc. do your own research. Early $AMD, $TSLA, $PLTR, $SPOT, $HIMS, $DUOL, $IBRX, $NAUT.
Joined November 2020
410 Following 163.7K Followers
Peptides are a write function. Biology is code.
The winner won’t be whoever makes the molecule.
It’ll be whoever owns the patient data and the AI that matches each person to the optimal write function.
That’s $HIMS.
Show more
everyone gave up on $HIMS in february 2026
the stock is up ~3X since
$hims is a not a GLP-1 company, but a Healthcare Ontology
$2,000/share intrinsic value by the year 2030
